Sarepta Therapeutics, Inc.
Peptide oligonucleotide conjugates
Last updated:
Abstract:
Provided herein are oligonucleotides, peptides, and peptide-oligonucleotide-conjugates. Also provided herein are methods of treating a muscle disease, a viral infection, or a bacterial infection in a subject in need thereof, comprising administering to the subject oligonucleotides, peptides, and peptide-oligonucleotide-conjugates described herein.
Status:
Grant
Type:
Utility
Filling date:
28 Apr 2020
Issue date:
24 Aug 2021